Variant report
Variant | esv3333680 |
---|---|
Chromosome Location | chr1:63216564-63218512 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:63216427..63219175-chr1:63247590..63249362,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540661799 | chr1:63216566-63216567 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs558915763 | chr1:63216619-63216620 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs34289527 | chr1:63216621-63216622 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs397713087 | chr1:63216630-63216631 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs143768188 | chr1:63216691-63216692 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542118941 | chr1:63216740-63216741 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs185110630 | chr1:63216752-63216753 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs531150249 | chr1:63216760-63216761 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs552464212 | chr1:63216869-63216870 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564629847 | chr1:63216897-63216898 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs528560084 | chr1:63216908-63216909 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs34495838 | chr1:63216927-63216928 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs552821460 | chr1:63216991-63216992 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs571675579 | chr1:63216993-63216994 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs187298046 | chr1:63217004-63217005 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs67985494 | chr1:63217026-63217027 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs547055074 | chr1:63217028-63217029 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs568470527 | chr1:63217035-63217036 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs138348776 | chr1:63217070-63217071 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs548522611 | chr1:63217087-63217088 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs189052382 | chr1:63217113-63217114 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs142454189 | chr1:63217149-63217150 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558456941 | chr1:63217194-63217195 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs570568441 | chr1:63217249-63217250 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534410779 | chr1:63217258-63217259 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs574460326 | chr1:63217283-63217284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs71643644 | chr1:63217291-63217292 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs536682876 | chr1:63217301-63217302 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs542895810 | chr1:63217318-63217319 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs71643645 | chr1:63217321-63217322 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561531578 | chr1:63217331-63217332 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs71643646 | chr1:63217334-63217335 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs200953836 | chr1:63217343-63217344 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs11809792 | chr1:63217344-63217345 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs181608596 | chr1:63217353-63217354 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs375563227 | chr1:63217362-63217363 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs185335555 | chr1:63217364-63217365 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs188581452 | chr1:63217369-63217370 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs180683317 | chr1:63217378-63217379 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs35301575 | chr1:63217379-63217380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs7522699 | chr1:63217387-63217388 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs575824206 | chr1:63217395-63217396 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs546410216 | chr1:63217396-63217397 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs200447600 | chr1:63217402-63217403 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs67017663 | chr1:63217403-63217404 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs11805080 | chr1:63217404-63217405 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs564958313 | chr1:63217411-63217412 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs146303094 | chr1:63217419-63217420 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs528652336 | chr1:63217421-63217422 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs12753662 | chr1:63217429-63217430 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Breast cancer | 16620391 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
CNS Malformation Syndrome | 17530927 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Type 2 diabetes | 21956041 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:63208800-63220400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
2 | chr1:63211000-63222200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr1:63212200-63217000 | Weak transcription | Fetal Stomach | stomach |
4 | chr1:63212400-63216600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr1:63212400-63216800 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
6 | chr1:63212400-63218600 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
7 | chr1:63215600-63217000 | Weak transcription | Liver | Liver |
8 | chr1:63215800-63217000 | Enhancers | Fetal Heart | heart |
9 | chr1:63216400-63217200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr1:63216600-63217200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
11 | chr1:63216800-63217200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr1:63216800-63217200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
13 | chr1:63216800-63217200 | Enhancers | Adipose Nuclei | Adipose |
14 | chr1:63216800-63217200 | Enhancers | HSMMtube | muscle |
15 | chr1:63217000-63217800 | Enhancers | Liver | Liver |
16 | chr1:63217000-63217800 | Enhancers | Ovary | ovary |
17 | chr1:63217000-63218400 | Enhancers | Aorta | Aorta |
18 | chr1:63217200-63220000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
19 | chr1:63217200-63220400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
20 | chr1:63217600-63222400 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
21 | chr1:63218200-63219000 | Weak transcription | Fetal Intestine Small | intestine |
22 | chr1:63218200-63219400 | Enhancers | Placenta | Placenta |
23 | chr1:63218400-63220000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |